APM
Avidity Partners Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-80,000
| Closed | -$9.93M | – | 69 |
|
2025
Q1 | $9.93M | Sell |
80,000
-154,500
| -66% | -$19.2M | 1.89% | 15 |
|
2024
Q4 | $28.9M | Sell |
234,500
-196,500
| -46% | -$24.2M | 2.84% | 11 |
|
2024
Q3 | $48M | Sell |
431,000
-113,500
| -21% | -$12.6M | 2.45% | 9 |
|
2024
Q2 | $58.1M | Sell |
544,500
-39,500
| -7% | -$4.22M | 2.47% | 11 |
|
2024
Q1 | $70.3M | Buy |
584,000
+94,881
| +19% | +$11.4M | 2.27% | 9 |
|
2023
Q4 | $60.2M | Sell |
489,119
-308,381
| -39% | -$37.9M | 2.19% | 12 |
|
2023
Q3 | $103M | Buy |
797,500
+94,722
| +13% | +$12.3M | 4.16% | 2 |
|
2023
Q2 | $87.1M | Buy |
702,778
+24,878
| +4% | +$3.08M | 3.04% | 3 |
|
2023
Q1 | $99.2M | Sell |
677,900
-49,641
| -7% | -$7.26M | 3.29% | 5 |
|
2022
Q4 | $116M | Buy |
727,541
+409,241
| +129% | +$65.2M | 2.51% | 13 |
|
2022
Q3 | $42.4M | Buy |
318,300
+256,300
| +413% | +$34.2M | 0.86% | 37 |
|
2022
Q2 | $9.67M | Buy |
+62,000
| New | +$9.67M | 0.22% | 51 |
|